Question: why is abbv stock dropping?
Answer: Shares of pharma giant AbbVie (NYSE:ABBV) dipped by 3.96% over the course of 2019, according to data from S&P Global Market Intelligence. ... International sales of AbbVie's flagship arthritis medicine, Humira, dropped markedly in 2019 due to the launch of biosimilars in key territories.